AXL Expression on Homeostatic Resident Liver Macrophages Is Reduced in Cirrhosis Following GAS6 Production by Hepatic Stellate Cells.
Pop OT; Geng A; Flint E; Singanayagam A; Ercan C; Possamai L; Patel VC; Kuenzler P; Meier MA; Soysal S; Hruz P; Kollmar O; Tatham KC; Ward JK; Müllhaupt B; Weber A; Wendon J; Niess JH; Heim M; Semela D; Weston C; Antoniades CG; Terracciano LM; Triantafyllou E; Brenig RG; Bernsmeier C. Cellular and Molecular Gastroenterology and Hepatology. 2023.IL-20 subfamily cytokines impair the oesophageal epithelial barrier by diminishing filaggrin in eosinophilic oesophagitis.
Kaymak T; Kaya B; Wuggenig P; Nuciforo S; Göldi A; Swiss EoE Cohort Study Group (SEECS); Oswald F; Roux J; Noti M; Melhem H; Hruz P; Niess JH. Gut. 2023.Surface protein and functional analyses identify CD4+CD39+ TCR αβ+ and activated TCR Vδ1+ cells with distinct pro-inflammatory functions in Crohn's Disease lesions.
Devan J; Nosi V; Spagnuolo J; Chancellor A; Beshirova A; Pedro Loureiro J; Vacchini A; Niess JH; Calogero R; Mori L; De Libero G; Hruz P. Clinical and Experimental Immunology. 2023.The gut microbiota-induced kynurenic acid recruits GPR35-positive macrophages to promote experimental encephalitis.
Miyamoto K; Sujino T; Harada Y; Ashida H; Yoshimatsu Y; Yonemoto Y; Nemoto Y; Tomura M; Melhem H; Niess JH; Suzuki T; Suzuki T; Suzuki S; Koda Y; Okamoto R; Mikami Y; Teratani T; Tanaka KF; Yoshimura A; Sato T; Kanai T. Cell Reports. 2023.[The IBD-Control questionnaire: German translation and validation of the standardized questionnaire for Patient Reported Outcome Measurement in inflammatory bowel disease].
Müller A; Bilger SS; Göldi A; Meinlschmidt G; Rueter F; Kappes A; Hruz P; Meier CA; Niess JH. Zeitschrift fur Gastroenterologie. 2022.Epithelial GPR35 protects from Citrobacter rodentium infection by preserving goblet cells and mucosal barrier integrity.
Melhem H; Kaya B; Kaymak T; Wuggenig P; Flint E; Roux J; Oost KC; Cavelti-Weder C; Balmer ML; Walser JC; Morales RA; Riedel CU; Liberali P; Villablanca EJ; Niess JH. Mucosal immunology. 2022.Experimental and genetic evidence for the impact of CD5 and CD6 expression and variation in inflammatory bowel disease.
Casadó-Llombart S; Velasco-de Andrés M; Català C; Leyton-Pereira A; Gutiérrez-Cózar R; Suárez B; Armiger N; Carreras E; Esteller M; Ricart E; Ordás I; Gisbert JP; Chaparro M; Esteve M; Márquez L; Busquets D; Iglesias E; García-Planella E; Martín-Arranz MD; Lohmann J; Ayata CK; Niess JH; Engel P; Panés J; Salas A; Domènech E; Lozano F; ENEIDA Project of GETECCU. Frontiers in immunology. 2022.Immune system and microbiome in the esophagus: implications for understanding inflammatory diseases.
Kaymak T; Hruz P; Niess JH. The FEBS journal. 2022.Stimulatory MAIT cell antigens reach the circulation and are efficiently metabolised and presented by human liver cells.
Lett MJ; Mehta H; Keogh A; Jaeger T; Jacquet M; Powell K; Meier MA; Fofana I; Melhem H; Vosbeck J; Cathomas G; Heigl A; Heim MH; Burri E; Mertz KD; Niess JH; Kollmar O; Zech CJ; Ivanek R; Duthaler U; Klenerman P; Stroka D; Filipowicz Sinnreich M. Gut. 2022.Targeting colonic macrophages improves glycemic control in high-fat diet-induced obesity.
Rohm TV; Keller L; Bosch AJT; AlAsfoor S; Baumann Z; Thomas A; Wiedemann SJ; Steiger L; Dalmas E; Wehner J; Rachid L; Mooser C; Yilmaz B; Fernandez Trigo N; Jauch AJ; Wueest S; Konrad D; Henri S; Niess JH; Hruz P; Ganal-Vonarburg SC; Roux J; Meier DT; Cavelti-Weder C. Communications Biology. 2022.The Selective 5-HT1A Agonist SR57746A Protects Intestinal Epithelial Cells and Enteric Glia Cells and Promotes Mucosal Recovery in Experimental Colitis.
Walldorf J; Porzner M; Neumann M; Joodi G; Niess JH; von Boyen G; Mäder K; Weissbach J; Kleger A; Seufferlein T. Inflammatory bowel diseases. 2022.Abdominal pain in patients with inflammatory bowel disease: association with single-nucleotide polymorphisms prevalent in irritable bowel syndrome and clinical management
Ledergerber M.; Lang B.M.; Heinrich H.; Biedermann L.; Begre S.; Zeitz J.; Krupka N.; Rickenbacher A.; Turina M.; Greuter T.; Schreiner P.; Roth R.; Siebenhuner A.; Vavricka S.; Rogler G.; Beerenwinkel N.; Misselwitz B.; Anderegg C.; Bauerfeind P.; Beglinger C.; Belli D.; Bengoa J.M.; Bigler B.; Binek J.; Blattmann M.; Boehm S.; Borovicka J.; Braegger C.P.; Brunner N.; Buhr P.; Burnand B.; Burri E.; Buyse S.; Cremer M.; Criblez D.H.; de Saussure P.; Degen L.; Delarive J.; Doerig C.; Dora B.; Dorta G.; Egger M.; Ehmann T.; El-Wafa A.; Engelmann M.; Ezri J.; Felley C.; Fliegner M.; Fournier N.; Fraga M.; Frei P.; Frei R.; Fried M.; Froehlich F.; Funk C.; Furlano R.I.; Gallot-Lavallee S.; Geyer M.; Girardin M.; Golay D.; Grandinetti T.; Gysi B.; Haack H.; Haarer J.; Helbling B.; Hengstler P.; Herzog D.; Hess C.; Heyland K.; Hinterleitner T.; Hiroz P.; Hirschi C.; Hruz P.; Iwata R.; Jost R.; Juillerat P.; Brondolo V.K.; Knellwolf C.; Knoblauch C.; Kohler H.; Koller R.; Krieger-Grubel C.; Kullak-Ublick G.; Kunzler P.; Landolt M.; Lange R.; Lehmann F.S.; Macpherson A.; Maerten P.; Maillard M.H.; Manser C.; Manz M.; Marbet U.; Marx G.; Matter C.; McLin V.; Meier R.; Mendanova M.; Meyenberger C.; Michetti P.; Misselwitz B.; Moradpour D.; Morell B.; Mosler P.; Mottet C.; Muller C.; Muller P.; Mullhaupt B.; Munger-Beyeler C.; Musso L.; Nagy A.; Neagu M.; Nichita C.; Niess J.; Noel N.; Nydegger A.; Obialo N.; Oneta C.; Oropesa C.; Peter U.; Peternac D.; Petit L.M.; Piccoli-Gfeller F.; Pilz J.B.; Pittet V.; Raschle N.; Rentsch R.; Restellini S.; Richterich J.-P.; Rihs S.; Ritz M.A.; Roduit J.; Rogler D.; Rossel J.-B.; Sagmeister M.; Saner G.; Sauter B.; Sawatzki M.; Schappi M.; Scharl M.; Schelling M.; Schibli S.; Schlauri H.; Uebelhart S.S.; Schnegg J.-F.; Schoepfer A.; Seibold F.; Seirafi M.; Semadeni G.-M.; Semela D.; Senning A.; Sidler M.; Sokollik C.; Spalinger J.; Spangenberger H.; Stadler P.; Steuerwald M.; Straumann A.; Straumann-Funk B.; Sulz M.; Thorens J.; Tiedemann S.; Tutuian R.; Viani F.; Vogtlin J.; Von Kanel R.; Vonlaufen A.; Vouillamoz D.; Vulliamy R.; Wermuth J.; Werner H.; Wiesel P.; Wiest R.; Wylie T.; Zimmermann D.. BMC GASTROENTEROLOGY. 2021.GPR35 in Intestinal Diseases: From Risk Gene to Function.
Kaya B; Melhem H; Niess JH. Frontiers in immunology. 2021.High Serum Creatine Kinase Levels in Infliximab and Vedolizumab-Treated Inflammatory Bowel Disease Patients.
Sutter M; Hruz P; Niess JH. Inflammatory intestinal diseases. 2021.Mucins Dynamics in Physiological and Pathological Conditions.
Melhem H; Regan-Komito D; Niess JH. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2021.Obesity in Humans Is Characterized by Gut Inflammation as Shown by Pro-Inflammatory Intestinal Macrophage Accumulation.
Rohm TV; Fuchs R; Müller RL; Keller L; Baumann Z; Bosch AJT; Schneider R; Labes D; Langer I; Pilz JB; Niess JH; Delko T; Hruz P; Cavelti-Weder C. Frontiers in immunology. 2021.Type D personality is associated with depressive symptoms and clinical activity in inflammatory bowel disease
Jordi S.B.U.; Botte F.; Lang B.M.; Greuter T.; Krupka N.; Auschra B.; Schreiner P.; Sulz M.C.; Biedermann L.; von Kanel R.; Rogler G.; Begre S.; Misselwitz B.; Anderegg C.; Bauerfeind P.; Beglinger C.; Belli D.; Bengoa J.M.; Bigler B.; Binek J.; Blattmann M.; Boehm S.; Borovicka J.; Braegger C.P.; Brunner N.; Buhr P.; Burnand B.; Burri E.; Buyse S.; Cremer M.; Criblez D.H.; de Saussure P.; Degen L.; Delarive J.; Doerig C.; Dora B.; Dorta G.; Egger M.; Ehmann T.; El-Wafa A.; Engelmann M.; Ezri J.; Felley C.; Fliegner M.; Fournier N.; Fraga M.; Frei P.; Frei R.; Fried M.; Froehlich F.; Funk C.; Furlano R.I.; Gallot-Lavallee S.; Geyer M.; Girardin M.; Golay D.; Grandinetti T.; Gysi B.; Haack H.; Haarer J.; Helbling B.; Hengstler P.; Herzog D.; Hess C.; Heyland K.; Hinterleitner T.; Hiroz P.; Hirschi C.; Hruz P.; Iwata R.; Jost R.; Juillerat P.; Brondolo V.K.; Knellwolf C.; Knoblauch C.; Kohler H.; Koller R.; Krieger-Grubel C.; Kullak-Ublick G.; Kunzler P.; Landolt M.; Lange R.; Lehmann F.S.; Macpherson A.; Maerten P.; Maillard M.H.; Manser C.; Manz M.; Marbet U.; Marx G.; Matter C.; McLin V.; Meier R.; Mendanova M.; Meyenberger C.; Michetti P.; Moradpour D.; Morell B.; Mosler P.; Mottet C.; Muller C.; Muller P.; Mullhaupt B.; Munger-Beyeler C.; Musso L.; Nagy A.; Neagu M.; Nichita C.; Niess J.; Noel N.; Nydegger A.; Obialo N.; Oneta C.; Oropesa C.; Peter U.; Peternac D.; Petit L.M.; Piccoli-Gfeller F.; Pilz J.B.; Pittet V.; Raschle N.; Rentsch R.; Restellini S.; Richterich J.-P.; Rihs S.; Ritz M.A.; Roduit J.; Rogler D.; Rossel J.-B.; Sagmeister M.; Saner G.; Sauter B.; Sawatzki M.; Schappi M.; Scharl M.; Schelling M.; Schibli S.; Schlauri H.; Uebelhart S.S.; Schnegg J.-F.; Schoepfer A.; Seibold F.; Seirafi M.; Semadeni G.-M.; Semela D.; Senning A.; Sidler M.; Sokollik C.; Spalinger J.; Spangenberger H.; Stadler P.; Steuerwald M.; Straumann A.; Straumann-Funk B.; Thorens J.; Tiedemann S.; Tutuian R.; Vavricka S.; Viani F.; Vogtlin J.; Vonlaufen A.; Vouillamoz D.; Vulliamy R.; Wermuth J.; Werner H.; Wiesel P.; Wiest R.; Wylie T.; Zeitz J.; Zimmermann D.. Alimentary Pharmacology and Therapeutics. 2021.Amoebic Liver Abscess in Crohn Disease Treated With Ustekinumab.
Rybinski F; Weisser M; Niess JH; Hruz P. Inflammatory bowel diseases. 2020.Evaluating the Cost-Effectiveness of Early Compared with Late or No Biologic Treatment to Manage Crohn's Disease using Real-World Data.
Pillai N; Lupatsch JE; Dusheiko M; Schwenkglenks M; Maillard M; Sutherland CS; Pittet VEH; Swiss IBD Cohort Study group .. Journal of Crohn's & colitis. 2020.Intestinal microbial metabolites in human metabolism and type 2 diabetes.
Herrema H; Niess JH. Diabetologia. 2020.Loss of the branched-chain amino acid transporter CD98hc alters the development of colonic macrophages in mice.
Wuggenig P; Kaya B; Melhem H; Ayata CK; Swiss IBD Cohort Investigators; Hruz P; Sayan AE; Tsumura H; Ito M; Roux J; Niess JH. Communications Biology. 2020.Lysophosphatidic Acid-Mediated GPR35 Signaling in CX3CR1(+) Macrophages Regulates Intestinal Homeostasis.
Kaya B; Doñas C; Wuggenig P; Diaz OE; Morales RA; Melhem H; Swiss IBD. Cohort Investigators; Hernández PP; Kaymak T; Das S; Hruz P; Franc Y; Geier F; Ayata CK; Villablanca EJ; Niess JH. Cell Reports. 2020.Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease
Serra E.G.; Schwerd T.; Moutsianas L.; Cavounidis A.; Fachal L.; Pandey S.; Kammermeier J.; Croft N.M.; Posovszky C.; Rodrigues A.; Russell R.K.; Barakat F.; Auth M.K.H.; Heuschkel R.; Zilbauer M.; Fyderek K.; Braegger C.; Travis S.P.; Satsangi J.; Parkes M.; Thapar N.; Ferry H.; Matte J.C.; Gilmour K.C.; Wedrychowicz A.; Sullivan P.; Moore C.; Sambrook J.; Ouwehand W.; Roberts D.; Danesh J.; Baeumler T.A.; Fulga T.A.; Karaminejadranjbar M.; Ahmed A.; Wilson R.; Barrett J.C.; Elkadri A.; Griffiths A.M.; Zurek M.; Strisciuglio C.; Elawad M.; Lo B.; Arancibia-Carcamo C.; Bailey A.; Barnes E.; Bird-Lieberman E.L.; Brain O.; Braden B.; Collier J.; East J.; Howarth L.; Keshav S.; Klenerman P.; Leedham S.; Palmer R.; Powrie F.; Simmons A.; Walker M.; Tolkien Z.; Kaptoge S.; Allen D.; Mehenny S.; Mant J.; Di Angelantonio E.; Thompson S.G.; Yilmaz B.; Juillerat P.; Geuking M.; Wiest R.; Macpherson A.J.; Bravo F.D.; Brugger L.; Carstens O.; Bigler U.G.; Heimgartner B.; Rusticeanu M.; Schmid (-Uebelhart) S.; Strebel B.; Tatu A.; Tutuian R.; Wiest R.; Oyas O.; Ramon C.; Stelling J.; Franc Y.; Fournier N.; Pittet V.; Burnand B.; Egger M.; Franc Y.; Golay D.; Marot A.; Musso L.; Pittet V.; Rossel J.-B.; Seematter V.; Sommer J.; Vulliamy R.; Michetti P.; Maillard M.H.; Keller C.; Maillard M.H.; Nydegger A.; Schoepfe A.; Archanioti E.; Ezri J.; Fraga M.; Schoepfer A.; Muller C.; Rogler G.; Biedermann L.; Blattmann M.; Burk S.; Dora B.; Fried M.; Misselwitz B.; Mullhaupt B.; Obialo N.; Pohl D.; Raschle N.; Scharl M.; Vavricka S.; Von Kanel R.; Zeitz J.; Abdelrahman K.; Ademi G.; Borovicka J.; Brand S.; Frei R.; Haarer J.; Knellwolf (-Grieger) C.; Krieger(-Grubel) C.; Kunzler P.; Meyenberger C.; Meyer P.; Rohrich N.; Sawatzki M.; Schelling M.; Semadeni G.-M.; Sulz M.; Zimmermann D.; Aepli P.; Criblez D.H.; Hess C.; Richterich J.-P.; Spalinger J.; Staudenmann D.; Stulz A.; Wohrle S.; Thomas A.; Anderegg C.; Kohler H.; Kusche R.; Antonino A.-T.; Arrigoni E.; Bengoa J.M.; Cunningham S.; de Saussure P.; Girard L.; de Jong D.B.; Basturk P.; Brunner S.; Degen L.; Hruz P.; Bakker C.K.-D.; Niess J.; Balsiger B.; Haldemann J.; Saner G.; Seibold F.; Bauerfeind P.; Becocci A.; Belli D.; Binek J.; Hengstler P.; Boehm S.; Boldanov T.; Buhr P.; Koller R.; Rueger V.; Senning A.; Burri E.; Buyse S.; Cao D.-T.; D'Angelo F.; Delarive J.; Doerig C.; Hessler R.; Preissler C.; Rentsch R.; Risti B.; Ritz M.A.; Steuerwald M.; Vogtlin J.; Sagmeister M.; Sauter B.; Schibli S.; Sokollik C.; Spalinger J.; Schlauri H.; Schnegg J.-F.; Seirafi M.; Spangenberger H.; Stadler P.; Staub P.; Stenz V.; Tempia-Caliera M.; Thorens J.; Truninger K.; Urfer P.; Viani F.; Vouillamoz D.; Zander S.; Wyli T.; Jostins L.; Kennedy N.A.; Ahmad T.; Lamb C.A.; Edwards C.; Hart A.; Hawkey C.; Mansfield J.C.; Mowat C.; Newman W.G.; Simmons A.; Tremelling M.; Lee J.C.; Prescott N.J.; Mathew C.G.; Lees C.W.; McGovern D.P.B.; Targan S.R.; Botwin G.; Mengesha E.; Fleshner P.; Landers C.; Li D.; Rioux J.D.; Bitton A.; Cote-Daigneault J.; Daly M.J.; Xavier R.; Morris K.; Boucher G.; Cho J.H.; Abraham C.; Merad M.; Sands B.; Peter I.; Hao K.; Itan Y.; Duerr R.H.; Konnikova L.; Schwartz M.B.; Proksell S.; Johnston E.; Miladinova V.; Chen W.; Brant S.R.; Datta L.; Silverberg M.S.; Schumm L.P.; Birch S.; Giri M.; Gettler K.; Sharma Y.; Stevens C.; Lazarev M.; Haritunians T.; Snapper S.B.; Shah N.; Muise A.M.; Wilson D.C.; Uhlig H.H.; Anderson C.A.. Nature Communications. 2020.The Copper/Zinc Ratio Correlates With Markers of Disease Activity in Patients With Inflammatory Bowel Disease.
Schneider T; Caviezel D; Ayata CK; Kiss C; Niess JH; Hruz P. Crohn's & colitis 360. 2020.[The Role of the Exposome in the Emergence of Chronic Inflammatory Bowel Diseases].
Niess JH; Kaymak T; Hruz P. Therapeutische Umschau. 2019.Editorial: The IL-20 Cytokines and Related Family Members in Immunity and Diseases.
Niess JH; Francés R. . 2019.Metabolite-Sensing G Protein-Coupled Receptors Connect the Diet-Microbiota-Metabolites Axis to Inflammatory Bowel Disease.
Melhem H; Kaya B; Ayata CK; Hruz P; Niess JH. Cells. 2019.NLRP6 Deficiency in CD4 T Cells Decreases T Cell Survival Associated with Increased Cell Death.
Radulovic K; Ayata CK; Mak'Anyengo R; Lechner K; Wuggenig P; Kaya B; Hruz P; Gomez de Agüero M; Broz P; Weigmann B; Niess JH. Journal of Immunology. 2019.Publisher Correction: Microbial network disturbances in relapsing refractory Crohn’s disease (Nature Medicine, (2019), 25, 2, (323-336), 10.1038/s41591-018-0308-z)
Yilmaz B.; Juillerat P.; Oyas O.; Ramon C.; Bravo F.D.; Franc Y.; Fournier N.; Michetti P.; Mueller C.; Geuking M.; Pittet V.E.H.; Maillard M.H.; Rogler G.; Abdelrahman K.; Ademi G.; Aepli P.; Thomas A.; Anderegg C.; Antonino A.-T.; Archanioti E.; Arrigoni E.; Bakker de Jong D.; Balsiger B.; Basturk P.; Bauerfeind P.; Becocci A.; Belli D.; Bengoa J.M.; Biedermann L.; Binek J.; Blattmann M.; Boehm S.; Boldanova T.; Borovicka J.; Braegger C.P.; Brand S.; Brugger L.; Brunner S.; Buhr P.; Burnand B.; Burk S.; Burri E.; Buyse S.; Cao D.-T.; Carstens O.; Criblez D.H.; Cunningham S.; D'Angelo F.; de Saussure P.; Degen L.; Delarive J.; Doerig C.; Dora B.; Drerup S.; Egger M.; El-Wafa A.; Engelmann M.; Ezri J.; Felley C.; Fliegner M.; Fournier N.; Fraga M.; Franc Y.; Frei P.; Frei R.; Fried M.; Froehlich F.; Furlano R.I.; Garzoni L.; Geyer M.; Girard L.; Girardin M.; Golay D.; Good I.; Graf Bigler U.; Gysi B.; Haarer J.; Halama M.; Haldemann J.; Heer P.; Heimgartner B.; Helbling B.; Hengstler P.; Herzog D.; Hess C.; Hessler R.; Heyland K.; Hinterleitner T.; Hirschi C.; Hruz P.; Juillerat P.; Khalid-de Bakker C.; Kayser S.; Keller C.; Knellwolf (-Grieger) C.; Knoblauch C.; Kohler H.; Koller R.; Krieger(-Grubel) C.; Kunzler P.; Kusche R.; Lehmann F.S.; Macpherson A.J.; Maillard M.H.; Manz M.; Marot A.; Meier R.; Meyenberger C.; Meyer P.; Michetti P.; Misselwitz B.; Mosler P.; Mottet C.; Muller C.; Mullhaupt B.; Musso L.; Neagu M.; Nichita C.; Niess J.; Nydegger A.; Obialo N.; Ollo D.; Oropesa C.; Peter U.; Peternac D.; Petit L.M.; Pittet V.; Pohl D.; Porzner M.; Preissler C.; Raschle N.; Rentsch R.; Restellini A.; Restellini S.; Richterich J.-P.; Ris F.; Risti B.; Ritz M.A.; Rohrich N.; Rossel J.-B.; Rueger V.; Rusticeanu M.; Sagmeister M.; Saner G.; Sauter B.; Sawatzki M.; Scharl M.; Schelling M.; Schibli S.; Schlauri H.; Schluckebier D.; Schmid D.; Schmid (-Uebelhart) S.; Schnegg J.-F.; Schoepfer A.; Seematter V.; Seibold F.; Seirafi M.; Semadeni G.-M.; Senning A.; Sokollik C.; Sommer J.; Spalinger J.; Spangenberger H.; Stadler P.; Staub P.; Staudenmann D.; Stenz V.; Steuerwald M.; Straumann A.; Strebel B.; Stulz A.; Sulz M.; Tatu A.; Tempia-Caliera M.; Thorens J.; Truninger K.; Tutuian R.; Urfer P.; Vavricka S.; Viani F.; Vogtlin J.; Von Kanel R.; Vouillamoz D.; Vulliamy R.; Wiesel P.; Wiest R.; Wohrle S.; Zamora S.; Zander S.; Wylie T.; Zeitz J.; Zimmermann D.; Wiest R.; Stelling J.; Macpherson A.J.. Nature Medicine. 2019.High Prevalence of Vitamin D Deficiency among Patients with Inflammatory Bowel Disease.
Caviezel D; Maissen S; Niess JH; Kiss C; Hruz P. Inflammatory intestinal diseases. 2018.Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach.
Raduolovic K; Mak'Anyengo R; Kaya B; Steinert A; Niess JH. Journal of Visualized Experiments. 2018.Low Discontinuation Rate of Infliximab Treatment in Steroid-Dependent/Refractory Crohn's Disease Patients.
Kaymak T; Moriconi F; Niess JH; Beglinger C; Hruz P. Inflammatory intestinal diseases. 2018.The Interleukin-20 Cytokines in Intestinal Diseases.
Niess JH; Hruz P; Kaymak T. Frontiers in Immunology. 2018.IL26 modulates cytokine response and anti-TNF consumption in Crohn's disease patients with bacterial DNA.
Piñero P; Juanola O; Gutiérrez A; Zapater P; Giménez P; Steinert A; Sempere L; González-Navajas JM; Niess JH; Francés R. Journal of molecular medicine (Berlin, Germany). 2017.Patient self-reported concerns in inflammatory bowel diseases: A genderspecific subjective quality-of-life indicator
Pittet V.; Vaucher C.; Froehlich F.; Burnand B.; Michetti P.; Maillard M.H.; Anderegg C.; Bauerfeind P.; Beglinger C.; Begre S.; Belli D.; Bengoa J.M.; Biedermann L.; Bigler B.; Binek J.; Blattmann M.; Boehm S.; Borovicka J.; Braegger C.P.; Brunner N.; Buhr P.; Burri E.; Buyse S.; Cremer M.; Criblez D.H.; De Saussure P.; Degen L.; Delarive J.; Doerig C.; Dora B.; Dorta G.; Egger M.; Ehmann T.; El-Wafa A.; Engelmann M.; Ezri J.; Felley C.; Fliegner M.; Fournier N.; Fraga M.; Frei P.; Frei R.; Fried M.; Funk C.; Furlano R.I.; Gallot-Lavallee S.; Geyer M.; Girardin M.; Golay D.; Grandinetti T.; Gysi B.; Haack H.; Haarer J.; Helbling B.; Hengstler P.; Herzog D.; Hess C.; Heyland K.; Hinterleitner T.; Hiroz P.; Hirschi C.; Hruz P.; Iwata R.; Jost R.; Juillerat P.; Brondolo V.K.; Knellwolf C.; Knoblauch C.; Kohler H.; Koller R.; Krieger-Grubel C.; Kullak-Ublick G.; Kunzler P.; Landolt M.; Lange R.; Lehmann F.S.; Macpherson A.; Maerten P.; Manser C.; Manz M.; Marbet U.; Marx G.; Matter C.; McLin V.; Meier R.; Mendanova M.; Meyenberger C.; Misselwitz B.; Moradpour D.; Morell B.; Mosler P.; Mottet C.; Muller C.; Muller P.; Mullhaupt B.; Munger-Beyeler C.; Musso L.; Nagy A.; Neagu M.; Nichita C.; Niess J.; Noel N.; Nydegger A.; Obialo N.; Oneta C.; Oropesa C.; Peter U.; Peternac D.; Petit L.M.; Piccoli-Gfeller F.; Pilz J.B.; Raschle N.; Rentsch R.; Restellini S.; Richterich J.-P.; Rihs S.; Ritz M.A.; Roduit J.; Rogler D.; Rogler G.; Rossel J.-B.; Rueger V.; Sagmeister M.; Saner G.; Sauter B.; Sawatzki M.; Schappi M.; Scharl M.; Scharl S.; Schelling M.; Schibli S.; Schlauri H.; Uebelhart S.S.; Schnegg J.-F.; Schoepfer A.; Seibold F.; Seirafi M.; Semadeni G.-M.; Semela D.; Senning A.; Sidler M.; Sokollik C.; Spalinger J.; Spangenberger H.; Stadler P.; Steuerwald M.; Straumann A.; Straumann-Funk B.; Sulz M.; Suter A.; Thorens J.; Tiedemann S.; Tutuian R.; Vavricka S.; Viani F.; Vogtlin J.; Von Kanel R.; Vonlaufen A.; Vouillamoz D.; Vulliamy R.; Wermuth J.; Werner H.; Wiesel P.; Wiest R.; Wylie T.; Zeitz J.; Zimmermann D.. PLoS ONE. 2017.The Stimulation of Macrophages with TLR Ligands Supports Increased IL-19 Expression in Inflammatory Bowel Disease Patients and in Colitis Models.
Steinert A; Linas I; Kaya B; Ibrahim M; Schlitzer A; Hruz P; Radulovic K; Terracciano L; Macpherson AJ; Niess JH. Journal of Immunology. 2017.A Pleiotropic Missense Variant in SLC39A8 Is Associated With Crohn's Disease and Human Gut Microbiome Composition.
Li D; Achkar JP; Haritunians T; Jacobs JP; Hui KY; D'Amato M; Brand S; Radford-Smith G; Halfvarson J; Niess JH; Kugathasan S; Büning C; Schumm LP; Klei L; Ananthakrishnan A; Aumais G; Baidoo L; Dubinsky M; Fiocchi C; Glas J; Milgrom R; Proctor DD; Regueiro M; Simms LA; Stempak JM; Targan SR; Törkvist L; Sharma Y; Devlin B; Borneman J; Hakonarson H; Xavier RJ; Daly M; Brant SR; Rioux JD; Silverberg MS; Cho JH; Braun J; McGovern DP; Duerr RH. Gastroenterology. 2016.Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells.
Rossini V; Radulovic K; Riedel CU; Niess JH. Journal of Visualized Experiments. 2016.Gastro-intestinal tract: The leading role of mucosal immunity.
Steinert A; Radulovic K; Niess J. Swiss medical weekly. 2016.Gastro-intestinal tract: The leading role of mucosal immunity.
Steinert A; Radulovic K; Niess J. Swiss medical weekly. 2016.Macroscopy predicts tumor progression in gastric cancer: A retrospective patho-historical analysis based on Napoleon Bonaparte's autopsy report.
Dawson H; Novotny A; Becker K; Reim D; Langer R; Gullo I; Svrcek M; Niess JH; Tutuian R; Truninger K; Diamantis I; Blank A; Zlobec I; Riddell RH; Carneiro F; Fléjou JF; Genta RM; Lugli A. DIGESTIVE AND LIVER DISEASE. 2016.Successful Treatment of Small Intestinal Bleeding in a Crohn's Patient with Noncirrhotic Portal Hypertension by Transjugular Portosystemic Shunt Placement and Infliximab Treatment.
Heimgartner B; Dawson H; De Gottardi A; Wiest R; Niess JH. Case reports in gastroenterology. 2016.CD69 is the crucial regulator of intestinal inflammation: a new target molecule for IBD treatment?
Radulovic K; Niess JH. Journal of immunology research. 2015.Anti-TNF and skin inflammation in IBD: a new paradox in gastroenterology?
Niess JH; Danese S. Gut. 2014.CX3CR1⁺ cells facilitate the activation of CD4 T cells in the colonic lamina propria during antigen-driven colitis.
Rossini V; Zhurina D; Radulovic K; Manta C; Walther P; Riedel CU; Niess JH. Mucosal immunology. 2014.Hypertrophy of infected Peyer's patches arises from global, interferon-receptor, and CD69-independent shutdown of lymphocyte egress.
Schulz O; Ugur M; Friedrichsen M; Radulovic K; Niess JH; Jalkanen S; Krueger A; Pabst O. Mucosal immunology. 2014.Age-of-onset-dependent influence of NOD2 gene variants on disease behaviour and treatment in Crohn's disease.
Posovszky C; Pfalzer V; Lahr G; Niess JH; Klaus J; Mayer B; Debatin KM; von Boyen GB. BMC GASTROENTEROLOGY. 2013.CD14-dependent monocyte isolation enhances phagocytosis of listeria monocytogenes by proinflammatory, GM-CSF-derived macrophages.
Neu C; Sedlag A; Bayer C; Förster S; Crauwels P; Niess JH; van Zandbergen G; Frascaroli G; Riedel CU. PLoS ONE. 2013.CX(3)CR1(+) macrophages support IL-22 production by innate lymphoid cells during infection with Citrobacter rodentium.
Manta C; Heupel E; Radulovic K; Rossini V; Garbi N; Riedel CU; Niess JH. Mucosal immunology. 2013.The early activation marker CD69 regulates the expression of chemokines and CD4 T cell accumulation in intestine.
Radulovic K; Rossini V; Manta C; Holzmann K; Kestler HA; Niess JH. PLoS ONE. 2013.